WALTHAM, MASS. - Alcresta Therapeutics, which develops enzyme-based treatments for rare diseases, has signed a 14,441-square-foot life sciences lease at 130 Turner Street, a 270,000-square-foot facility located in the western [...] The post Alcresta Therapeutics Signs 14,441 SF Life Sciences Lease in Waltham, Massachusetts appeared first on REBusinessOnline.
Alcresta is a Massachusetts-based pharmaceutical company that researches, develops, and markets novel enzyme-based products for the treatment of gastrointestinal disorders.